Skip to main content

A Nov. 5 article, "Biotech CEO Profits as Stock Tanks," reported erroneously that Titan Pharmaceuticals (TTP:NYSE) CEO Louis Bucalo failed to disclose publicly an October 2000 stock collar transaction until October 2002. In fact, Bucalo disclosed this hedge transaction in a Form 4 dated Nov. 6, 2000 and timely filed with the Securities and Exchange Commission. (corrected Nov. 6. regrets the error)

TheStreet Recommends